SG Americas Securities, LLC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$1,875,000
+405.4%
167,417
+396.1%
0.02%
+433.3%
Q2 2017$371,000
+34.9%
33,748
+20.3%
0.00%
+50.0%
Q1 2017$275,000
+46.3%
28,047
+60.7%
0.00%0.0%
Q4 2016$188,000
+37.2%
17,449
+40.3%
0.00%
+100.0%
Q1 2016$137,000
-84.6%
12,437
-90.3%
0.00%
-80.0%
Q3 2015$892,000
+913.6%
128,589
+1184.9%
0.01%
Q4 2014$88,000
+54.4%
10,008
-19.9%
0.00%
Q1 2014$57,00012,4940.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders